Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298. Case and Commentary Feb 2022 How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work? Tabitha E. H. Moses, MS and Arash Javanbakht, MD Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes. AMA J Ethics. 2022;24(2):E111-119. doi: 10.1001/amajethics.2022.111. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298.
Case and Commentary Feb 2022 How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work? Tabitha E. H. Moses, MS and Arash Javanbakht, MD Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes. AMA J Ethics. 2022;24(2):E111-119. doi: 10.1001/amajethics.2022.111.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.